These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29600483)

  • 1. Updated guide for the management of malignant hyperthermia.
    Riazi S; Kraeva N; Hopkins PM
    Can J Anaesth; 2018 Jun; 65(6):709-721. PubMed ID: 29600483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.
    Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB
    Anesth Analg; 2014 Dec; 119(6):1359-66. PubMed ID: 25268394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant hyperthermia.
    Rosenberg H; Davis M; James D; Pollock N; Stowell K
    Orphanet J Rare Dis; 2007 Apr; 2():21. PubMed ID: 17456235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Malignant hyperthermia--diagnostics, treatment and anaesthetic management].
    Schuster F; Müller-Reible CR
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Nov; 44(11-12):758-63; quiz 764. PubMed ID: 19918708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant hyperthermia].
    Metterlein T; Schuster F; Graf BM; Anetseder M
    Anaesthesist; 2014 Dec; 63(12):908-18. PubMed ID: 25384957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant hyperthermia in Mazovia Province - are we adequately prepared?
    Cieniewicz A; Trzebicki J
    Anaesthesiol Intensive Ther; 2022; 54(2):99-102. PubMed ID: 35579281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant hyperthermia].
    Schulte-Sasse U; Eberlein HJ
    Anaesthesist; 1983 Apr; 32(4):141-57. PubMed ID: 6349413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant Hyperthermia.
    Kaur H; Katyal N; Yelam A; Kumar K; Srivastava H; Govindarajan R
    Mo Med; 2019; 116(2):154-159. PubMed ID: 31040503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant hyperthermia.
    McNeil B
    Br J Perioper Nurs; 2005 Sep; 15(9):376-7, 379-82. PubMed ID: 16178207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of malignant hyperthermia crisis during anesthesia].
    Amiel I; Nivoche Y
    Ann Fr Anesth Reanim; 1989; 8(5):427-34. PubMed ID: 2697157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JSA guideline for the management of malignant hyperthermia crisis 2016.
    Safety Committee of Japanese Society of Anesthesiologists
    J Anesth; 2017 Apr; 31(2):307-317. PubMed ID: 28246924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant hyperthermia: clinical and molecular aspects.
    Correia AC; Silva PC; da Silva BA
    Rev Bras Anestesiol; 2012; 62(6):820-37. PubMed ID: 23176990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia: an OR emergency!
    Plast Surg Nurs; 2000; 20(4):222-6. PubMed ID: 12025057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.
    Larach MG; Gronert GA; Allen GC; Brandom BW; Lehman EB
    Anesth Analg; 2010 Feb; 110(2):498-507. PubMed ID: 20081135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare genetic variant of the ryanodine receptor in a suspected malignant hyperthermia susceptible patient.
    MacKay EJ; Wilkerson C; Kraeva N; Rosenberg H; Kennedy T
    J Clin Anesth; 2016 Sep; 33():144-6. PubMed ID: 27555149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular conditions associated with malignant hyperthermia in paediatric patients: A 25-year retrospective study.
    Bamaga AK; Riazi S; Amburgey K; Ong S; Halliday W; Diamandis P; Guerguerian AM; Dowling JJ; Yoon G
    Neuromuscul Disord; 2016 Mar; 26(3):201-6. PubMed ID: 26951757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed Development of Malignant Hyperthermia Following Cardiopulmonary Bypass.
    Sams SH; Revilla S; Stahl DL
    Semin Cardiothorac Vasc Anesth; 2018 Mar; 22(1):95-99. PubMed ID: 28922985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant hyperthermia.
    Halliday NJ
    J Craniofac Surg; 2003 Sep; 14(5):800-2. PubMed ID: 14501352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of malignant hyperthermia in patients administered triggering agents before malignant hyperthermia susceptibility identified: missed opportunities prior to diagnosis.
    Chan TY; Bulger TF; Stowell KM; Gillies RL; Langton EE; Street NE; Pollock NA
    Anaesth Intensive Care; 2017 Nov; 45(6):707-713. PubMed ID: 29137581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group.
    Glahn KP; Ellis FR; Halsall PJ; Müller CR; Snoeck MM; Urwyler A; Wappler F;
    Br J Anaesth; 2010 Oct; 105(4):417-20. PubMed ID: 20837722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.